3
Announcements
Trials
Browse
Landscape
Status
Unknown
2
Completed
1
Sponsor Class
INDUSTRY
3
Study Type
Observational
3
Sponsor
Conditions
Neoplasms
14
Pain
13
Cancer Pain
6
Breakthrough Pain
4
Breakthrough Cancer Pain
3
Chronic Pain
2
Burns
2
Anemia, Sickle Cell
2
Agnosia
2
Waldenstrom Macroglobulinemia
1
Vulvar Neoplasms
1
Vipoma
1
Vaginal Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Urethral Neoplasms
1
Thymoma
1
Thrombocythemia, Essential
1
Testicular Neoplasms
1
Stomach Neoplasms
1
Standard Opioid Analgesic Treatment of Cancer-related Chronic Pain.
1
Squamous Cell Carcinoma of Head and Neck
1
Somatostatinoma
1
Small Cell Lung Carcinoma
1
Sezary Syndrome
1
Sarcoma
1
Salivary Gland Neoplasms
1
Respiratory Insufficiency
1
Rectal Neoplasms
1
Quality of Life
1
Interventions
Fentanyl
3
Nasal Sprays
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
3 trials
Recent
Start date
Enrollment
INDUSTRY
×
Breakthrough Cancer Pain
×
Fentanyl
×
Clear all
NCT03895762
2022-05-05
OASIS
A.Menarini Asia-Pacific Holdings Pte Ltd
Completed
143 enrolled
NCT01693328
2014-01-15
Qualipec
Archimedes Development Ltd
Unknown
300 enrolled
NCT01698645
2013-07-11
Qualipec
Archimedes Development Ltd
Unknown
150 enrolled